drugset / Trial / NCT02290002

Calcium Dobesilate Versus Coasting for Prevention of Ovarian Hyperstimulation Syndrome

NCT02290002

Phase 2/3 Completed 200 enrolled khalid abd aziz mohamed
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to compare the effect of oral Calcium Dobesilate versus costing in the prevention of ovarian hyperstimulation syndrome (OHSS) in high-risk women underwent intracytoplasmic sperm injection (ICSI).

Timeline

Start
2014-06
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcium Dobesilate Unknown 500 mg Oral

Indications